Rest Of Asia Pacific Bioinformatics Market (2026-2031)
The Rest Of Asia Pacific Bioinformatics Market was valued at $462.1 Million in 2026 and projected to reach to $799.7 Million by 2031, representing a compound annual growth rate of 11.6%. Rest Of Asia Pacific represents a compelling growth opportunity within the broader Asia Pacific bioinformatics ecosystem.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Rest Of Asia Pacific Bioinformatics Market Trends and Insights
- The region's bioinformatics market was valued at $462.1 million in 2026 and is forecast to expand to $799.7 million by 2031, reflecting a compound annual growth rate of 11.6%.
- This expansion is driven by increasing investments in genomic research, rising adoption of precision medicine, and growing healthcare digitalization across emerging economies in Rest Of Asia Pacific. Rest Of Asia Pacific's bioinformatics sector is characterized by accelerating demand for data analytics solutions in drug discovery and clinical diagnostics.
- The region benefits from a large patient population, expanding pharmaceutical R&D capabilities, and government initiatives supporting biotechnology innovation.
- Rest Of Asia Pacific is positioning itself as a key hub for bioinformatics applications, with particular strength in agricultural genomics and personalized healthcare initiatives through 2031. The competitive environment in Rest Of Asia Pacific continues to intensify as both regional and global players establish operations to capture market share.
- Rest Of Asia Pacific's growth trajectory underscores the region's strategic importance in the global bioinformatics ecosystem, supported by improving infrastructure and talent availability..
Key Market Statistics
- CAGR (2026-2031) 11.6% CAGR
- Market Size, 2026 ~USD 462.1 Million
- Forecast, 2031 ~USD 799.7 Million
- Country Rest Of Asia Pacific
Rest Of Asia Pacific Bioinformatics Market Overview
Market Valuation Growth :
Rest Of Asia Pacific bioinformatics market valued at $462.1 million in 2026, expanding to $799.7 million by 2031, representing 73% growth over the forecast period.
Regional CAGR Performance :
The region demonstrates a 11.6% CAGR from 2026-2031, slightly below the global average of 13.1%, indicating steady but measured market maturation across emerging Asia Pacific economies.
Genomic Research Investment :
Increasing government and private sector investments in genomic research initiatives across Rest Of Asia Pacific countries are driving adoption of bioinformatics solutions and infrastructure development.
Precision Medicine Adoption :
Rising adoption of precision medicine and personalized healthcare approaches in Rest Of Asia Pacific is accelerating demand for advanced bioinformatics platforms and analytical tools.
Rest Of Asia Pacific Bioinformatics Market Dynamics
- The region's market expansion from $462.1 million to $799.7 million reflects increasing healthcare modernization and biotechnology investments across emerging economies.
- Key drivers include enhanced genomic research funding, growing precision medicine initiatives, and improving healthcare infrastructure. The 11.6% CAGR trajectory indicates sustained market development through 2031, supported by rising pharmaceutical R&D activities and academic research collaborations.
- While slightly trailing global growth rates, the region's bioinformatics market benefits from cost-effective solutions, expanding biotech hubs, and increasing government support for life sciences innovation.
- Strategic partnerships and technology transfer initiatives will further accelerate market penetration in Rest Of Asia Pacific..
Market Ecosystem
BIOINFORMATICS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Provides bioinformatics solutions for genomic data analysis, next-generation sequencing (NGS) workflows, molecular diagnostics, and life science research. Its platforms support sequencing data interpretation, variant analysis, and clinical research applications. | Faster genomic data analysis, improved accuracy in variant interpretation, streamlined NGS workflows, enhanced research productivity, and support for precision medicine development. |
 |
Offers integrated sequencing and bioinformatics platforms for analyzing large-scale genomic data. Its solutions support applications in oncology, inherited disease research, population genomics, and clinical diagnostics through advanced sequencing data analysis. | Efficient management of complex genomic datasets, improved disease identification, faster biomarker discovery, enhanced clinical decision-making, and acceleration of personalized medicine. |
 |
Provides bioinformatics software and genomic analysis platforms for sample-to-insight workflows, molecular diagnostics, clinical research, and next-generation sequencing data interpretation. | Simplified data analysis, improved workflow automation, reliable genomic insights, reduced analysis time, and enhanced support for molecular testing and precision healthcare. |
 |
Develops bioinformatics tools for genomics, transcriptomics, and molecular analysis, supporting applications such as microarray analysis, NGS data interpretation, and biomarker discovery in research and clinical settings. | Improved data visualization and interpretation, increased research efficiency, accurate molecular profiling, faster discovery of biological insights, and optimized laboratory workflows. |
 |
Provides integrated bioinformatics solutions supporting clinical genomics, companion diagnostics, oncology research, and precision medicine. Its platforms enable genomic data analysis for targeted therapies and biomarker identification. | Enhanced biomarker assessment, faster treatment decisions, improved diagnostic accuracy, optimized clinical workflows, and support for personalized medicine approaches. |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
Related Ecosystem
Healthcare It
- Computed Tomography (CT)
- Machine Learning
- Magnetic Resonance Imaging (MRI)
- Natural Language Processing (NLP)
- Predictive Analytics
- CERNER CORPORATION
- PHILIPS HEALTHCARE
- Oracle Corporation
- GE HealthCare Technologies Inc.
- Siemens healthineers
Pharmaceuticals
- Bioreactors
- Analytical Testing
- Bioanalytical Testing Services
- Cell Counters
- Data Management Services
- Thermo Fisher Scientific Inc.
- SANOFI
- Merck KGaA
- NOVARTIS
- Pfizer Inc.
Key Takeaways
- Rest Of Asia Pacific's bioinformatics market is projected to grow from $462.1M (2026) to $799.7M (2031) at an 11.6% CAGR.
- Rest Of Asia Pacific is experiencing accelerating adoption of precision medicine and genomic research applications across healthcare systems.
- Rest Of Asia Pacific benefits from large patient populations and expanding pharmaceutical R&D investments driving market expansion.
- Rest Of Asia Pacific's competitive landscape is intensifying with both regional and global bioinformatics providers establishing regional operations.
Bioinformatics Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | PRECISION MEDICINE (Use Case) |
| Forecast Period | 2026-2031 |
| Growth Rate | CAGR of 13.1% from 2026 to 2031 |
| Largest Segment | SOFTWARE (Offering) |
| Market Size Base Year (Billions) | ~USD 18.59 (2026) |
| Revenue Forecast (Billions) | ~USD 34.41 (2031) |
| Segments Covered | Offering, Type, Function, Use Case, Sector, End User |
Rest Of Asia Pacific Bioinformatics Market Report Segmentation
6 segment dimensions are covered across the global market.
By Offering
- Services
- Software
By Type
- Chemoinformatics Solutions
- Cloud & Managed Bioinformatics
- Cloud & Managed Services
- Consulting & Custom Bioinformatics Development
- Data Analysis & Interpretation
- Database & Data Management
- Drug Discovery & Target Identification
- End-To-End Solutions
- Gene Expression Analysis
- Generalized Knowledge Management Tools
- Genomics Solutions
- Knowledge Management Tool
- Metabolomics Solutions
- Multi-Omics Solutions
- Multiomics Solutions
- Niche Point Solutions
- Other Bioinformatics Services
- Other Data Analysis Functions
- Other End-To-End Solutions
- Other Services
- Proteomics Solutions
- Sequence Analysis
- Sequencing & Data Generation
- Specialized Knowledge Management Tools
- Transcriptomics Solutions
- Variant Analysis
By Function
- Clinical Interpretation
- Data Analysis
- Data Visualization & Reporting
- Multiomics Integration
- Other Functions
- Structural & Functional Analysis
By Use Case
- Biomarker Discovery
- Clinical Diagnostics
- Drug Discovery & Development
- Other Use Cases
- Precision Medicine
- Research & Academic Applications
By Sector
- Animal Biotechnology
- Environmental Biotechnology
- Forensic Biotechnology
- Medical Biotechnology
- Other Sectors
- Plant Biotechnology
By End User
- Academic & Research Institutes
- Contract Research Organizations And Contract Development & Manufacturing Organizations
- Government & Public Health Organizations
- Hospitals & Clinical Diagnostic Laboratories
- Other End Users
- Pharmaceutical & Biotechnology Companies
Target Audience
- Bioinformatics Software Vendors : Need Rest Of Asia Pacific-specific market data to identify expansion opportunities, assess market readiness, and develop region-tailored product strategies for genomic analysis and precision medicine platforms.
- Healthcare & Pharmaceutical Companies : Require detailed market insights on Rest Of Asia Pacific bioinformatics adoption rates, regulatory environments, and investment trends to guide R&D localization and clinical trial operations.
- Investment & Private Equity Firms : Need comprehensive Rest Of Asia Pacific market forecasts and growth drivers to evaluate biotech investment opportunities, identify acquisition targets, and assess portfolio company expansion potential.
- Government & Healthcare Policy Makers : Utilize Rest Of Asia Pacific bioinformatics market data to inform healthcare digitalization initiatives, genomic research funding decisions, and precision medicine policy development.
- Research Institutions & Academic Centers : Require market intelligence on Rest Of Asia Pacific bioinformatics infrastructure, funding landscape, and technology adoption to guide research collaborations and institutional strategic planning.
Key Companies in the Rest Of Asia Pacific Bioinformatics Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| BECKMAN COULTER | United States | Private Company | Bioinformatics Software (Genomics, Multiomics, Proteomics),Bioinformatics Services (Analysis, Sequencing, Genomic Services), |
| WUXI APPTEC | China | Public Company | Chemical Business,Testing Services,Biological Services, |
| DANAHER CORPORATION | United States | Public Company | Diagnostics,Life Sciences (Excl. Biotechnology),Biotechnology, |
| THERMO FISHER SCIENTIFIC INC. | United States | Public Company | Life Sciences Solutions,Analytical Instruments,Specialty Diagnostics, |
| ILLUMINA, INC. | United States | Public Company | Sequencing and array-based instruments,Consumables (reagents, flow cells, library preparation, WGS and targeted kits),Services (whole-genome sequencing, genotyping, NIPT, product support, informatics services), |
| QIAGEN N.V. | Netherlands | Public Company | Bioinformatics software (genomics, multiomics, proteomics),Bioinformatics-linked services (analysis, sequencing, interpretation),Non-bioinformatics consumables and instruments, |
| AGILENT TECHNOLOGIES, INC. | United States | Public Company | Agilent CrossLab,Life Sciences and Diagnostics Markets,Applied Markets, |
| REVVITY, INC. | United States | Public Company | Life Sciences,Diagnostics, |
| EUROFINS SCIENTIFIC | Luxembourg | Public Company | Bioinformatics-linked genomics and multiomics services,Non-informatics analytical testing (food, environment, consumer, other), |
| BGI GENOMICS | China | Public Company | Sequencing and Bioinformatics Services,Clinical Testing and Precision Medicine Solutions,Mass Spectrometry and Multi-omics (Proteomics, Metabolomics, Multi-omics Integration), |
| WATERS CORPORATION | United States | Public Company | Waters Segment (LC-MS systems, consumables, and software),Materials Sciences Division (thermal analysis, rheometry, calorimetry), |
| OXFORD NANOPORE TECHNOLOGIES PLC | United Kingdom | Public Company | Sequencing instruments (MinION, GridION, PromethION),Consumables and flow cells,Software and bioinformatics services, |
| 10X GENOMICS | United States | Public Company | Single-cell and spatial instruments (Chromium, Chromium X Series, Visium, Xenium Analyzer, CytAssist),Consumables and reagents (microfluidic chips, slides, kits including QuantumScale),Bioinformatics software and analysis services (Cell Ranger, Loupe Browser, Xenium Explorer, associated analysis support), |
| PACBIO | United States | Public Company | Sequencing instruments (Revio, Vega, Sequel, Onso),Consumables (SMRT cells, SMRTbell prep kits, binding and sequencing kits),Software and services (bioinformatics analysis, sequencing services, collaborations), |
| SIEMENS AG | Germany | Public Company | Industrial Businesses (IB) - Siemens Healthineers,Industrial Businesses (IB) - Smart Infrastructure,Industrial Businesses (IB) - Digital Industries, |
| SOPHIA GENETICS | Switzerland | Public Company | SOPHiA DDM Software Platform (Genomics, Multiomics, Proteomics),Services (Analysis Support, Sequencing-Linked Informatics, Implementation), |
BECKMAN COULTER
Beckman Coulter is a private American company founded in 1935 that employs 11,900 people. The company operates in the life sciences and diagnostics sector.
WUXI APPTEC
WuXi AppTec is a public Chinese company founded in 2000 with 35,584 employees. The company provides pharmaceutical and biotechnology research and development services.
DANAHER CORPORATION
Danaher Corporation is a public American company founded in 1969 with 59,000 employees. The company operates across multiple sectors including life sciences, diagnostics, and environmental solutions.
THERMO FISHER SCIENTIFIC INC.
Thermo Fisher Scientific Inc. is a public American company founded in 1956 with 125,000 employees. The company is a leading provider of laboratory equipment, reagents, and services for life sciences research and diagnostics.
ILLUMINA, INC.
Illumina, Inc. is a public American company founded in 1998 with 8,625 employees. The company specializes in DNA sequencing and genetic analysis technologies.
QIAGEN N.V.
QIAGEN N.V. is a public Dutch company founded in 1984 with 5,500 employees. The company develops and manufactures molecular diagnostics and life sciences products.
AGILENT TECHNOLOGIES, INC.
Agilent Technologies, Inc. is a public American company founded in 1999 with 18,000 employees. The company provides analytical instruments, software, and services for life sciences and diagnostics.
REVVITY, INC.
Revvity, Inc. is a public American company founded in 1937 with 11,000 employees. The company provides analytical instruments and life sciences solutions.
EUROFINS SCIENTIFIC
Eurofins Scientific is a public Luxembourg-based company founded in 1987 with 65,694 employees. The company operates a network of laboratories providing testing and analytical services across multiple industries.
BGI GENOMICS
BGI Genomics is a public Chinese company founded in 1999 with 3,580 employees. The company specializes in genomic sequencing and genetic analysis services.
WATERS CORPORATION
Waters Corporation is a public American company founded in 1958 with 7,900 employees. The company manufactures analytical instruments and software for laboratory testing and research.
OXFORD NANOPORE TECHNOLOGIES PLC
Oxford Nanopore Technologies PLC is a public British company founded in 2005 with 1,316 employees. The company develops nanopore-based DNA and RNA sequencing technologies.
10X GENOMICS
10X Genomics is a public American company founded in 2012 with 1,178 employees. The company develops single-cell and spatial genomics solutions for research and diagnostics.
PACBIO
PacBio is a public American company founded in 2000 with 485 employees. The company develops long-read DNA sequencing technologies and systems.
SIEMENS AG
Siemens AG is a public German company founded in 1847 with 317,000 employees. The company operates across multiple sectors including industrial automation, energy, healthcare, and infrastructure.
SOPHIA GENETICS
Sophia Genetics is a public Swiss company founded in 2011 with 415 employees. The company provides AI-powered genomic analysis and interpretation software for clinical diagnostics.
Reasons to Buy this Report
- Regional Market Sizing & Forecasts : Obtain precise market valuation data specific to Rest Of Asia Pacific ($462.1M in 2026, $799.7M in 2031) with detailed CAGR analysis to support investment decisions and business planning.
- Growth Driver Analysis : Understand key catalysts fueling the 11.6% CAGR in Rest Of Asia Pacific, including genomic research investments, precision medicine adoption, and healthcare infrastructure modernization trends.
- Competitive Landscape Intelligence : Identify market opportunities and competitive positioning within Rest Of Asia Pacific's emerging bioinformatics sector, distinct from mature Asia Pacific markets like Japan and Australia.
- Strategic Market Entry Planning : Leverage Rest Of Asia Pacific-specific insights to develop targeted go-to-market strategies, partnership opportunities, and localization approaches for bioinformatics solutions and services.
- Investment & Expansion Justification : Support capital allocation decisions and business case development with comprehensive Rest Of Asia Pacific market data, demonstrating 73% growth potential through 2031.
Frequently asked questions
What is the market size of bioinformatics in Rest Of Asia Pacific?
Rest Of Asia Pacific's bioinformatics market was valued at $462.1 million in 2026 and is expected to reach $799.7 million by 2031.
What is the growth rate for bioinformatics in Rest Of Asia Pacific?
Rest Of Asia Pacific's bioinformatics market is projected to grow at a compound annual growth rate (CAGR) of 11.6% from 2026 to 2031.
What are the primary drivers of bioinformatics growth in Rest Of Asia Pacific?
Rest Of Asia Pacific's bioinformatics growth is driven by increasing genomic research investments, precision medicine adoption, healthcare digitalization, and government biotechnology initiatives.
Which applications are most prominent in Rest Of Asia Pacific's bioinformatics market?
Rest Of Asia Pacific shows particular strength in drug discovery analytics, clinical diagnostics, agricultural genomics, and personalized healthcare applications.
How competitive is the bioinformatics market in Rest Of Asia Pacific?
Rest Of Asia Pacific's bioinformatics market is increasingly competitive, with both regional players and global providers establishing operations to capture growing market opportunities.
RESEARCH METHODOLOGY
This research study involved the extensive use of both primary and secondary sources. It analyzed various factors affecting the industry to identify segmentation types, industry trends, key players, the competitive landscape of market players, and key market dynamics such as drivers, opportunities, challenges, restraints, and key player strategies.
Secondary Research
This research study extensively used secondary sources, including directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva, as well as white papers, annual reports, and companies' house documents. The secondary research aimed to gather and analyze information for a comprehensive, commercially focused study of the bioinformatics market, covering technical aspects and market dynamics. It also helped identify key players, market classifications, industry trends, geographic markets, and significant market developments. Additionally, a database of prominent industry leaders was compiled through secondary research.
Primary Research
In the primary research process, various supply-side and demand-side sources were interviewed to gather qualitative and quantitative information for this report. Primary supply-side sources included industry experts such as CEOs, VPs, managing directors, marketing and sales heads/directors, marketing managers, regional/area sales managers, and bioinformatics scientists. Primary demand-side sources included personnel from pharmaceutical and biotechnology companies, hospitals, diagnostic laboratories, and academic and research institutes.
A breakdown of the primary respondents is provided below:
*Others include sales managers, marketing managers, and product managers.
Note: Tiers are defined based on a company’s total revenue, as of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The total size of the bioinformatics market was determined after data triangulation using the two approaches outlined below. After each approach was completed, the weighted average of the two approaches was calculated based on the level of assumptions used in each approach.
Bioinformatics Market : Top-Down and Bottom-Up Approach
Data Triangulation
The size of the bioinformatics market was estimated through segmental extrapolation using the bottom-up approach. The methodology is as follows:
- Revenue information of individual companies was gathered from public sources and databases.
- The share of leading players in the bioinformatics market was obtained from secondary sources to the extent available. In certain cases, shares of bioinformatics businesses have been ascertained after a detailed analysis of various parameters, including product portfolios, market positioning, selling price, and geographic reach and strength.
- Individual shares or revenue estimates were validated through interviews with experts.
- The total revenue in the bioinformatics market was determined by extrapolating the market share data of major companies.
Market Definition
Bioinformatics is the application of computer technology to the management and analysis of biological data. It encompasses the storage, analysis, and dissemination of biological data. Bioinformatics uses computer programs for a variety of applications, including determining gene and protein functions, establishing evolutionary relationships, and predicting the three-dimensional shapes of proteins.
Key Stakeholders
- Bioinformatics software and service providers
- Academic & research institutes
- Clinical & diagnostic laboratories
- Hospitals & healthcare providers
- Contract research organizations (CROs)
- Distributors and suppliers of bioinformatics software and services
- Pharmaceutical & biotechnology companies
- Market research and consulting firms
- Venture capitalists
Report Objectives
- To define, describe, and forecast the bioinformatics market based on offering, function, use case, sector, end user, and region
- To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall bioinformatics market
- To analyze opportunities for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa.
- To profile the key players and analyze their market share and core competencies2
- To track and analyze competitive developments such as product launches & approvals, partnerships, agreements, and collaborations in the overall bioinformatics market
- To benchmark players within the market using the proprietary "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy.
Available customizations:
With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:
- Company Information
- Detailed analysis and profiling of additional market players (up to 5)
Product Analysis
- Further breakdown of the Rest of Asia Pacific market into Taiwan, New Zealand, Thailand, Singapore, Malaysia, and other countries
- Further breakdown of the Rest of Europe bioinformatics market into Russia, Austria, Finland, Turkey, Norway, Poland, Portugal, Romania, Denmark, and other countries
Get the Full Bioinformatics Market Report
Full forecast, segment splits, and company analysis for all Bioinformatics Market.
- Canada Bioinformatics Market
- US Bioinformatics Market
- Germany Bioinformatics Market
- UK Bioinformatics Market
- France Bioinformatics Market
- Italy Bioinformatics Market
- Spain Bioinformatics Market
- China Bioinformatics Market
- Japan Bioinformatics Market
- India Bioinformatics Market
- Australia Bioinformatics Market
- South Korea Bioinformatics Market
- Brazil Bioinformatics Market
- Mexico Bioinformatics Market
- Saudi Arabia Bioinformatics Market
- UAE Bioinformatics Market
- South Africa Bioinformatics Market
- Rest Of Europe Bioinformatics Market
- Rest Of Latin America Bioinformatics Market
- GCC Countries Bioinformatics Market
- Rest Of GCC Bioinformatics Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
